Search research articles
Contact Us
Filters
Showing results (61-70 of 95) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma
S M Ansell, T M Habermann, P J Kurtin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2015
A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma
T E Witzig, G S Nowakowski, T M Habermann, et al.
World Journal of Surgery
|
July 1, 1992
Non-Hodgkin's lymphoma of the thyroid: is more than biopsy necessary?
C M Pyke, C S Grant, T M Habermann, et al.
Human Pathology
|
July 1, 1994
Polymorphic reticulosis: a reappraisal
J G Strickler, M F Meneses, T M Habermann, et al.
American Journal of Clinical Pathology
|
September 1, 1990
Rapid immunotyping of B-cell non-Hodgkin's lymphomas by flow cytometry. A comparison with the standard frozen-section method
T E Witzig, P M Banks, M J Stenson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 1, 1995
Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations
R C Walker, C V Paya, W F Marshall, et al.
Acta Haematologica
|
January 1, 1995
Management of stage IE primary gastric lymphoma
E D Durr, J A Bonner, J G Strickler, et al.
Blood
|
November 26, 1999
Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma
C A Hanson, P J Kurtin, J A Katzmann, et al.
American Journal of Clinical Pathology
|
March 1, 1989
Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure
T E Witzig, N J Gonchoroff, P R Greipp, et al.
Leukemia
|
June 22, 2007
Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas
L F Porrata, K Ristow, T E Witzig, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 95) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma
S M Ansell, T M Habermann, P J Kurtin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2015
A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma
T E Witzig, G S Nowakowski, T M Habermann, et al.
World Journal of Surgery
|
July 1, 1992
Non-Hodgkin's lymphoma of the thyroid: is more than biopsy necessary?
C M Pyke, C S Grant, T M Habermann, et al.
Human Pathology
|
July 1, 1994
Polymorphic reticulosis: a reappraisal
J G Strickler, M F Meneses, T M Habermann, et al.
American Journal of Clinical Pathology
|
September 1, 1990
Rapid immunotyping of B-cell non-Hodgkin's lymphomas by flow cytometry. A comparison with the standard frozen-section method
T E Witzig, P M Banks, M J Stenson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 1, 1995
Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations
R C Walker, C V Paya, W F Marshall, et al.
Acta Haematologica
|
January 1, 1995
Management of stage IE primary gastric lymphoma
E D Durr, J A Bonner, J G Strickler, et al.
Blood
|
November 26, 1999
Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma
C A Hanson, P J Kurtin, J A Katzmann, et al.
American Journal of Clinical Pathology
|
March 1, 1989
Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure
T E Witzig, N J Gonchoroff, P R Greipp, et al.
Leukemia
|
June 22, 2007
Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas
L F Porrata, K Ristow, T E Witzig, et al.
Page
of 10